The company will not receive any of the proceeds from the sale of the shares by the selling stockholder.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EKSO:
- Ekso Bionics’ Earnings Call: Growth Amid Challenges
- Ekso Bionics price target lowered to $1 from $2 at Lake Street
- Ekso Bionics: Strategic Partnerships and Financial Health Drive Buy Rating with $9 Price Target
- Ekso Bionics Reports Record Q4 Revenue and Strategic Partnership
- Ekso Bionics reports Q4 EPS (14c) vs. (22c) last year
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue